Private Capital Group’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Private Capital Group’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3K	Buy	+530	New	+$1.82K	﹤0.01%	1474

Other funds holding RAIN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Private Capital Group's RAIN Position: Q2 2022 in Review

Private Capital Group opened a new position in Rain Oncology Inc. Common Stock (RAIN) in Q2 2022: 530 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1474 among its holdings.

40 funds tracked by Wall St. Rank hold RAIN as of Q2 2022.

Private Capital Group held 530 shares of Rain Oncology Inc. Common Stock worth $3K as of Q2 2022.
Rain Oncology Inc. Common Stock was a new Private Capital Group position in Q2 2022.
Rain Oncology Inc. Common Stock made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1474 holding.
40 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.